Aravax will present topline Phase 2 clinical trial results for [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

Early Phase 1b data show five objective responses among six [...]

Agenus has reported deep tumour responses and no observed colorectal [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

The first UK patient has been dosed with a personalised [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

NICE has recommended cemiplimab for eligible adults with recurrent or [...]